Video

Value-based care spawns new challenges for MS physicians


 

REPORTING FROM THE CMSC ANNUAL MEETING


“If I’m in an ACO, and I’m taking care of a lot of MS patients, I’ll already lose money for the accountable care system,” Dr. English said. “They may not necessarily want an MS center inside an ACO.”

What can doctors do? “Advocacy efforts are pretty difficult for physicians,” Dr. English said. “Our hope is that the CMSC will be a clearinghouse for doctors who have ideas and efforts and advocacy, and somehow channel that into the actual provision of care. You have people advocating for medications and for research and for patients, but there’s nobody advocating for the actual care that’s going on, the boots-on-the-ground care. That’s where CMSC should play a big role.”

Dr. English disclosed that he has served as a consultant for multiple pharmaceutical companies.

Pages

Recommended Reading

Interim Results Show Efficacy for a Novel MS Drug
ICYMI Multiple Sclerosis
Interferon treatment does not increase stroke risk in MS
ICYMI Multiple Sclerosis
Ocrelizumab safety update: Encouraging rates of serious infection, malignancy
ICYMI Multiple Sclerosis
Wide variety of MS topics on tap at CMSC 2018
ICYMI Multiple Sclerosis
Rehabilitation in MS is hot topic at CMSC 2018
ICYMI Multiple Sclerosis
CMSC looks to increase advocacy efforts to address looming concerns
ICYMI Multiple Sclerosis
DMTs Are Associated With Reduced Stroke Risk in Patients With MS
ICYMI Multiple Sclerosis
AAN Publishes Practice Guideline on DMTs for MS
ICYMI Multiple Sclerosis
Do Cardiovascular Risk Factors Contribute to Brain Atrophy in MS?
ICYMI Multiple Sclerosis
iPad app puts cognitive screening in the hands of MS patients
ICYMI Multiple Sclerosis